SMTI SANARA MEDTECH INC revenue, earnings and financials
For the quarter ended June 30, 2026, SANARA MEDTECH INC reported revenue of $28.1M (up 9.0% from a year earlier), net income of −$453K and diluted EPS of −$0.05; over the last four quarters revenue was $110M and net income $43.1M; for the fiscal year ended December 2025 revenue was $103M, up 19.0% on the year before.
SMTI annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $103M, gross profit $95.6M, operating income $7.30M, net income $37.6M (margin 36.4%), EPS −$4.36
- Fiscal year ended Dec 2024: revenue $86.7M, gross profit $78.5M, operating income $1.26M, net income $9.66M (margin 11.2%), EPS −$1.14
- Fiscal year ended Dec 2023: revenue $65.0M, gross profit $57.1M, operating income −$4.22M, net income $4.30M (margin 6.6%), EPS −$0.52
- Fiscal year ended Dec 2022: revenue $45.8M, gross profit $39.5M, operating income −$12.5M, net income −$7.94M (margin -17.3%), EPS −$1.00
- Fiscal year ended Dec 2021: revenue $24.1M, gross profit $21.8M, operating income −$7.38M, net income −$7.92M (margin -32.8%), EPS −$1.08
SMTI quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $28.1M (up 9.0% year over year), net income −$453K, EPS −$0.05
- Quarter ended Mar 31, 2026: revenue $27.8M (up 18.6% year over year), net income $459K, EPS $0.05
- Quarter ended Dec 31, 2025 (from the annual report): revenue $27.5M (up 4.7% year over year), net income $73.5M, EPS −$0.32
- Quarter ended Sep 30, 2025: revenue $26.3M (up 21.5% year over year), net income −$30.4M, EPS −$3.40
- Quarter ended Jun 30, 2025: revenue $25.8M (up 28.0% year over year), net income −$2.01M, EPS −$0.23
- Quarter ended Mar 31, 2025: revenue $23.4M (up 26.4% year over year), net income −$3.53M, EPS −$0.41
- Quarter ended Dec 31, 2024 (from the annual report): revenue $26.3M (up 48.7% year over year), net income $17.8M, EPS −$0.18
- Quarter ended Sep 30, 2024: revenue $21.7M (up 35.2% year over year), net income −$2.86M, EPS −$0.34
- Quarter ended Jun 30, 2024: revenue $20.2M (up 28.0% year over year), net income −$3.50M, EPS −$0.41
- Quarter ended Mar 31, 2024: revenue $18.5M (up 19.4% year over year), net income −$1.76M, EPS −$0.21
- Quarter ended Dec 31, 2023 (from the annual report): revenue $17.7M (up 15.5% year over year), net income $8.37M, EPS −$0.03
- Quarter ended Sep 30, 2023: revenue $16.0M (up 22.8% year over year), net income −$1.06M, EPS −$0.13
- Quarter ended Jun 30, 2023: revenue $15.8M (up 62.9% year over year), net income −$1.83M, EPS −$0.22
- Quarter ended Mar 31, 2023: revenue $15.5M (up 98.7% year over year), net income −$1.18M, EPS −$0.14
- Quarter ended Dec 31, 2022 (from the annual report): revenue $15.3M (up 1925.2% year over year), net income −$4.11M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $13.0M (up 124.0% year over year), net income −$1.47M, EPS −$0.18
- Quarter ended Jun 30, 2022: revenue $9.67M (up 54.1% year over year), net income $769K, EPS $0.09
- Quarter ended Mar 31, 2022: revenue $7.81M (down 30.8% year over year), net income −$3.13M, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue $756K, net income −$3.48M, EPS −$0.48
- Quarter ended Sep 30, 2021: revenue $5.82M, net income −$2.05M, EPS −$0.27
SMTI cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $6.79M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$23.8K, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$3.25M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$5.55M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$4.81M, share buybacks n/a
SMTI balance sheet
- Jun 30, 2026: cash $15.4M, total assets $69.1M, total liabilities $61.2M, shareholders' equity $7.94M, long-term debt $46.5M
- Mar 31, 2026: cash $13.6M, total assets $69.3M, total liabilities $62.3M, shareholders' equity $7.03M, long-term debt $46.2M
- Dec 31, 2025: cash $16.6M, total assets $72.9M, total liabilities $67.0M, shareholders' equity $5.94M, long-term debt $46.0M
- Sep 30, 2025: cash $14.9M, total assets $71.1M, total liabilities $64.9M, shareholders' equity $6.15M, long-term debt $45.1M
- Jun 30, 2025: cash $17.0M, total assets $98.8M, total liabilities $63.4M, shareholders' equity $35.4M, long-term debt $44.2M
- Mar 31, 2025: cash $20.7M, total assets $96.4M, total liabilities $59.7M, shareholders' equity $36.7M, long-term debt $43.4M
- Dec 31, 2024: cash $15.9M, total assets $88.1M, total liabilities $49.2M, shareholders' equity $39.4M, long-term debt $30.7M
- Sep 30, 2024: cash $16.3M, total assets $88.5M, total liabilities $49.1M, shareholders' equity $39.8M, long-term debt $30.1M
What is SMTI's revenue?
SANARA MEDTECH INC reported $110M of revenue over its last four quarters, through June 30, 2026.
Is SMTI profitable?
Yes. SANARA MEDTECH INC earned $43.1M over the last four quarters.
What is SMTI's EPS?
Diluted earnings per share over the last four quarters were −$3.72; −$0.05 in the latest quarter.